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Percent stenosisStudies in human and non-human primates have conﬁrmed the compensatory enlargement or positive remod-
eling (Glagov phenomenon) of coronary vessels in the presence of focal stenosis. To our knowledge, this is the
ﬁrst study to document arterial enlargement in ametabolic syndrome animalmodel with diffuse coronary artery
disease (DCAD) in the absence of severe focal stenosis. Two different groups of Ossabawminiature pigs were fed
a high fat atherogenic diet for 4 months (Group I) and 12 months (Group II), respectively. Group I (6 pigs)
underwent contrast enhanced computed tomographic angiography (CCTA) and intravascular ultrasound
(IVUS) at baseline and after 4 months of high fat diet, whereas Group II (7 pigs) underwent only IVUS at 12
months of high fat diet. IVUS measurements of the left anterior descending (LAD), left circumﬂex (LCX) and
right coronary (RCA) arteries in Group I showed an average increase in their lumen cross-sectional areas (CSA)
of 25.8%, 11.4%, and 43.4%, respectively, as compared to baseline. The lumen CSA values of LAD in Group II
were found to be between the baseline and 4 month values in Group I. IVUS and CCTA measurements showed
a similar trend and positive correlation. Fractional ﬂow reserve (FFR) was 0.91 ± 0.07 at baseline and 0.93 ±
0.05 at 4monthswith only 2.2%, 1.6% and 1% stenosis in the LAD, LCX and RCA, respectively. The relation between
percent stenosis and lumen CSA shows a classical Glagov phenomenon in this animal model of DCAD.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is anopen access article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Post-mortem and in vivo studies suggest that coronary artery diam-
eter increases as a consequence of atherosclerosis [1–7]. This phenome-
non, also known as the Glagov phenomenon, is characterized by an
outward enlargement of the vessel wall (positive remodeling) without
compromise of the lumen area during the early stages of atherosclerosis
[2]. It has also been reported [2] that the capacity for compensatory pos-
itive remodeling ceaseswhen the plaque occupies approximately 40% of
the potential lumen area. The phenomenonwas described in a histolog-
ical autopsy study twenty ﬁve years ago [2] and has since been demon-
strated in vivo in humans using intravascular ultrasound (IVUS) [1,3,5,7,
8], epicardial echocardiogram [4], and contrast enhanced computed to-
mographic angiography (CCTA) [6].
It is generally accepted that coronary atherosclerosis is a geometri-
cally focal and eccentric disease [9], and that coronary lesions evolvevations Institute, 11107 Roselle
418; fax: +1 858 249 7419.
land Ltd. This is an open access articlein an independent manner [10]. Hemodynamic forces regulate vascular
structure, as well as inﬂuence the development of atherosclerosis and
other pathologies [11–13]. Several studies [11–14] on wall shear stress
(WSS) have provided new insights into the contribution of the endothe-
lium to the development of coronary artery disease and vascular
remodeling.
The purpose of this atherosclerosis progression study was to assess
the presence of coronary arterial enlargement during the early stages
of the disease in a metabolic syndrome Ossabaw swine model known
to develop both diffuse and focal coronary artery disease [15].2. Methods
2.1. Animal model and study design
All animal experimentswere performed in accordancewith national
and local ethical guidelines, including the Principles of Laboratory Ani-
mal Care, the Guide for the Care and Use of Laboratory Animals [16]
and the National Association for Biomedical Research [17], and anunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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tocol regarding the use of animals in research.
Thirteen 9-month-old Ossabawminiature pigs of either sexwere di-
vided into 2 groups. The Ossabaw body weight at baseline was 41.7 ±
1.9 kg, 74.2 ± 4.3 kg at 4 months, and 116.8 ± 8.6 kg after 12 months
of high fat atherogenic diet [18]. The diet was composed of 6% to
8% kcal from proteins, 19% kcal from complex carbohydrates, and 46%
to 75% kcal from hydrogenated soy bean oil (predominantly trans
fatty acids), and 2% cholesterol and 0.7% cholate by weight [18]. Six
Ossabaw pigs (Group I) were fed 3200 kcal daily for 4 months, and
seven Ossabaw pigs (Group II) were fed the same diet for 12 months,
until they were euthanized. Five 4-month-old body weight-matched
Yorkshire domestic pigs (Group III), of either sex, that were fed with a
lean diet for 4 monthswere used as the control group because Ossabaw
miniature pigs do not grow when fed a lean diet [19]. The pigs were
housed and fed in individual pens and had ad libitum access to water.
A room temperature of 68–72 °F and humidity of 30% to 70% were
maintained.
At a scheduled time, the pigs were fasted overnight. Surgical anes-
thesia was induced with TKX (telazol 10 mg/kg, ketamine 5 mg/kg,
xylazine 5 mg/kg) and maintained with isoﬂurane 2–4%. Ventilation
with 100% O2 was provided with a respirator and maintained PCO2
at approximately 35 mmHg. Electrocardiographic (ECG) leads
were attached to the swine limbs. Body temperature was kept at
37.5 °C–38 °C and pH at 7.4 ± 0.1.
2.2. Imaging procedures
• Contrast enhanced computed tomographic angiography (CCTA)
CCTA is a clinically usedmodality that allows the identiﬁcation of cor-
onary lesions with excellent accuracy. CCTA scans were obtained by a
cardiovascular radiologist at baseline and at 4 months (Group I) on a
64 detector computed tomography system (Philips Brilliance 64,
Cleveland, OH). Images were acquired with a slice thickness of
0.625 mm and a reconstruction interval of 0.3 mm. The rotation
timewas 0.4 s with a pitch of 0.2, 120 kVp, and 1050mAs. A XCB ﬁlter
was used for reconstructions. The images were reconstructed at 5%,
15%, 25%… 75%, 85% and 95% of the R–R interval. The scan was per-
formed during end-inspiratory breath-hold using retrospective ECG-
gating. Intravenous lidocaine hydrochloride (60 μg/kg/min) and met-
oprolol (5 mg every minute up to a maximum dose of 25 mg) were
administered to maintain the heart rate below 60 beats per minute.
An intravenous injection of nitroglycerin (1.5 mg) was slowly admin-
istered to cause coronary vasodilation. Coronary arterial image acqui-
sition was performed using 60–80 mL (3.5 to 5 mL/s) of intravenous
contrast material (Isovue-370) followed by 100 mL of normal saline
ﬂush.
• CCTA imaging analysis
Image segmentation of CT datawas used to extract themain trunks of
the LAD, LCX and RCA by a previously validated algorithm developed
by our group [20]. The segmentation data contained the central line
coordinate and diameter. Since some of the image segmentation re-
quired manual operation on the more complex structures, pre-
processing and post-processingwere introduced to reduce themanu-
al load and to improve the accuracy. These processes included simple
segmentation of surrounding regions and 3-D edit of visualized ob-
jects. The segmented vessels were binarized and then processed by
isosurface rendering. Once the 3-D visualization functions were com-
pleted in Matlab, the vessel surface was represented by triangle mesh
and saved as STL ﬁles. MeshLab [21] was used to view the 3-D coro-
nary tree and reﬁne the structure. The list of faces and vertices in
the STL ﬁle was then converted into typical patch structures to pro-
vide the spatial connectedness in terms of faces and vertices, where
faces were the index of three vertices in one triangle, and vertices
were the X, Y, Z coordinate of each vertex.The lumen cross-sectional area (CSA) was determined by computa-
tion of the intersection of a plane with the vessel surface. The surface
was deﬁned by a set of vertices connected by faces forming the sur-
face. The intersection plane was deﬁned by a point and a normal vec-
tor. The point lied on the central line and the normal vector pointed to
the direction of a pair of continuous points along the central line. The
lumen CSA was obtained by calculating intersection segments of tri-
angle patches of the vessel surface with the plane. All calculated seg-
ments were linked to each other to form a continuous intersection
region. The lumen CSA measurements included in the analysis were
taken every 5 mm along the length of the coronary vessels, starting
at the ostium, once the entire vessel was reconstructed. Anatomical
landmarks such as vessel branches were used to overlap the position
of each section to the position determined by IVUS.
• Intravascular ultrasound (IVUS)
IVUS is a catheter-based technique that provides tomographic images
perpendicular to the length of the coronary arteries. It provides im-
portant information regarding plaque composition and distribution.
IVUS also provides vessel and lumen diameters that are fundamental
in the evaluation of a coronary lesion. Coronary angiography and
IVUS imaging were performed by a trained physician following stan-
dard procedures of clinical practice at baseline and at 4 months
(Group I), and at 12months (Group II). The femoral arterywas cannu-
lated with a 7 Fr introducer sheath and after full anticoagulation with
heparin (100 IU/kg), a 6 Fr guiding catheter (Mach 1, HS SH, Boston
Scientiﬁc, MA)was advanced over a 0.035″ guide wire into the select-
ed coronary artery (LAD, LCX and RCA). The animals received 200 μg
of intracoronary nitroglycerin before advancing the IVUS catheter. A
3.6 Fr, 40-MHz coronary imaging catheter (Atlantis SR Pro, Boston
Scientiﬁc, MA)was advanced over a 0.014″ guidewire and positioned
in the lumen of the distal portion of the artery where the vessel had a
diameter of approximately 1.5 mm. An automatic and continuous
pullback (0.5 mm/s) was performed from the distal position to the
proximal portion, allowing visualization of the entire length of the
coronary artery. IVUS images were recorded on S-VHS videotape, dig-
itized and analyzed off-line using NIS-Elements AR 3.2 software
(Nikon, Japan).
• IVUS imaging analysis
Still pictures from the digitized images were taken every 5 mm along
the length of the coronary arteries starting at the ostium. The position
along the vessel was normalized with respect to the total length, and
the results were expressed in terms of the fractional longitudinal po-
sition, ranging from 0 (most proximal, at inlet of coronary artery) to
1 (vessel diameter of about 1.5 mm). The same normalization process
was applied to the CCTA images to make sure that the same vessel
length was used for the analysis of both IVUS and CCTA images.
IVUS landmarks such as side branches were used in matching the
sites of the baseline and 4 month images, and to overlap the sections
measured with IVUS to the sections measured with CCTA. Frames
during the diastolic phase of the cardiac cycle were used for measure-
ments. Using the NIS-Elements software a calibration was performed
by measuring 1-mm grid marks encoded in the IVUS image. Manual
planimetry was used to trace the leading edges of the luminal border.
The lumen CSA and the diameter of each segment were calculated.
• Hemodynamic studies
Immediately after IVUS imaging, a 0.014″ pressure/ﬂow (combo)
guidewire (Volcano Corporation, Rancho Cordova, CA)was calibrated
and introduced into the guiding catheter. The wire was advanced up
to the tip of the guiding catheter, where the pressure measured
through the guiding catheter was veriﬁed to be equal to the pressure
measured by the combo wire. The combo wire was then advanced
into the coronary artery and intracoronary adenosine (120 μg) was
administered to achieve steady-state hyperemia. Fractional Flow Re-
serve (FFR) was measured during maximal hyperemia. Recordings
were taken at the distal, middle and proximal portions of the coronary
arteries. A FFR value of ≤0.80 was considered ﬂow limiting.
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The data were expressed as means ± 1SD. Statistical signiﬁcance of
the results was assessed using SigmaStat software (Systat Software,
Point Richmond, CA). The differences were evaluated with student's
t-test or two-way ANOVA, where appropriate. The Siegel–Tukey test
(non-parametric test) was also used to conﬁrm the statistical analysis.
p b 0.05 was considered statistically signiﬁcant.
3. Results
The lumen CSA data in Group I correspond to measurements
performed at the beginning of the study (before the atherogenic diet
was initiated, i.e., baseline) and after 4 months of atherogenic diet in
the same animals for LAD, LCX and RCA. When the baseline IVUS mea-
surements were compared to the 4 month measurements there was
an average (over the length of the vessel; LAD 70 ± 3.73 mm, LCXFig. 1. A) IVUS lumen CSA of LAD artery of Ossabaw pigs at baseline, 4 months and 12
months of atherogenic diet. B) IVUS lumen CSA of LCX of Ossabaw pigs at baseline and 4
months of atherogenic diet. C) IVUS lumen CSA of RCA of Ossabaw pigs at baseline and
4 months of atherogenic diet. The data is expressed as mean ± 1SD.51.3 ± 3.21 mm, and RCA 86.3 ± 4.63 mm) increase in the lumen
area from 5.8 ± 2.2 mm2 to 7.2 ± 2.3 mm2 (p = 0.006) in the LAD
(Fig. 1A), from 4.1 ± 1.0 mm2 to 4.5 ± 1.0 mm2 (p= 0.21) in the LCX
(Fig. 1B), and from 5.5 ± 0.7 mm2 to 7.9 ± 1.1 mm2 (p = 4.05E-09)
in the RCA (Fig. 1C).
The lumen area of the LAD artery at baseline and at 4 months
(Group I) was compared to the lumen area of the LAD from the animals
on atherogenic diet for 12 months (Group II). The CSA values at
12 months were 11.8% smaller when compared to the 4 months
lumen area (6.3 ± 1.5 mm2 vs. 7.2 ± 2.3 mm2, p = 0.22, Fig. 1A)
probably due to the higher percent stenosis (0 to 61.3%) at 12 months.
The lumen area of the LAD and RCA arteries (the two main coro-
naries that showed the most signiﬁcant positive remodeling) from
Group I at 4 months was compared to the lumen area of Group III. The
CSA values of the LAD from fractional longitudinal position 0 to 0.5
were very similar in both groups (p = 0.5), whereas the values from
fractional longitudinal position 0.6 to 1 were signiﬁcantly larger in
Group I (p= 0.001), Fig. 2A. The same was found in the RCA (p= 0.5
and p=0.03, respectively), Fig. 2B. Our study shows signiﬁcant positive
remodeling in the distal portions of the coronary arteries as compared
to the most proximal portions in the main trunks.
Fig. 3A and B show the CCTA reconstructed LAD and LCX trunks in
one representative animal from Group I at baseline (Fig. 3A) and at 4
months (Fig. 3B). Based on these CCTA images, the lumen CSA was de-
termined for Group I, as summarized in Fig. 3C and D. The CCTA
lumen CSA increased from 5.2 ± 0.5 mm2 to 7.7 ± 1.0 mm2 (p =
1.39E-05) in the LAD (Fig. 3C), and from 4.4 ± 0.6 mm2 to 5.2 ±
0.3 mm2 (p= 0.09) in the LCX (Fig. 3D).Fig. 2. Lumen CSA at 4 months from six Ossabaw (atherogenic diet) and ﬁve Yorkshire
(lean diet) pigs in A) LAD and B) RCA coronary arteries. The data is expressed as
mean ± 1SD.
Fig. 3. LAD and LCX trunk reconstructionwith center lines from one representativeOssabaw pig from CCTA images at A) baseline and B) 4months. CCTA lumen CSA from six Ossabaw pigs
(Group I) at baseline and 4 months of C) LAD artery and D) LCX artery. The data is expressed as mean ± 1SD.
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CCTA showed similar results and trends for both methods [p= 0.15 at
baseline (Fig. 4A) and p= 0.11 at 4 months (Fig. 4B) for LAD, and p=
0.34 at baseline (Fig. 4C) and p = 0.06 at 4 months (Fig. 4D) for LCX].
Hence, CCTA conﬁrmed the IVUS ﬁndings of arterial enlargement.
Fig. 5 shows the linear regression (Fig. 5A) and Bland–Altman
(Fig. 5B) accuracy analysis for the IVUS lumen area vs. the CCTA
lumen area. The mean difference between IVUS and CCTA was 0.06 ±
1.49 mm2 (accuracy p=NS).
The average percent stenosis determined by IVUS in Group I at 4
months was 2.2% ± 0.8% (0 to 3.32%) over the length of the LAD,
1.6% ± 0.9% (0 to 3.51%) for LCX, and 1% ± 0.8% (0 to 1.94%) for RCA,
as shown in Fig. 6A. The values were not statistically different in the
three arteries. The percent stenosis in Group II at 12 months in theLAD was 21.3% ± 14.2%, ranging from 0% to 61.3% (Fig. 6B). The results
from Groups I and II were signiﬁcantly different, p = 0.03. FFR values
in Group I were within normal ranges at baseline (0.91 ± 0.07) and at
4 months (0.93 ± 0.05), p= 0.71, Fig. 6C.
To demonstrate the positive remodeling, we plotted the lumen area
versus the percent stenosis at 12 months (Fig. 7). There was no signiﬁ-
cant relation between lumen CSA and percent stenosis below and above
35% stenosis (r valueswere 0.09 and 0.12, respectively), which conﬁrms
positive arterial remodeling.
4. Discussion
The major ﬁnding of this study was that Ossabaw pigs fed a high fat
atherogenic diet developed diffuse coronary artery disease (DCAD) over
Fig. 4. Comparison of IVUS and CCTAmeasurements of LAD artery CSA at A) baseline and B) 4 months. Comparison of IVUS and CCTAmeasurements of LCX artery at C) baseline and D) 4
months. The data is expressed as mean ± 1SD.
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area) during the early stages of the disease. Furthermore, after 12
months on atherogenic diet, a decrease in lumen CSA was observed,
but it was still greater than that observed at baseline (Fig. 1A). Several
studies [1–8] have shown arterial positive remodeling in the presence
of focal disease but to our knowledge, this is the ﬁrst report of a com-
pensatory enlargement of the coronary arteries in a metabolic syn-
drome animal model with DCAD during the early stages of the disease.
The Ossabaw swine develop metabolic syndrome when fed an
excess calorie atherogenic diet over several months [19]. All the patho-
logical aspects of the animals' metabolic syndrome (hypertension, dys-
lipidemia, glucose intolerance, endothelial dysfunction, steatohepatitis,
aswell as atherosclerosis in the coronary vasculature) have been exten-
sively described by several investigators [15,19,22,23]. Furthermore, the
Ossabaw swine model of metabolic syndrome also develops mature,
clinically signiﬁcant atheroma with lipid cores, foam cells, proliferating
smooth muscle cells, and small foci of calciﬁcation [15,24,25].
Positive remodeling is themechanismbywhich the lumenCSA of ar-
teries is preserved despite the development of atherosclerotic disease.
The phenomenon was ﬁrst described in human histopathologic speci-
mens 25 years ago by Glagov and colleagues [2]. The investigators also
reported that arterial enlargement occurred in relation to plaque bur-
den (33.3%, mean) and that lumen stenosis was not present until the
plaque occupied 40% of the lumen CSA [2]. Further accumulation of
plaque resulted in decrease of lumen area. Since then, several studies
have demonstrated the “Glagov phenomenon” in coronary arteries [1,
3] and peripheral arteries [8] of patients undergoing IVUS [1,3,8] or
CCTA [6]. It has been suggested [26] that the increase in lumen CSA is
largely compensatory; i.e., an adaptation to thickness of the intima to
preserve vessel function.Arterial vessels enlarge in response to a number of factors like body
weight or heart size [26], age [27], and blood ﬂow [28,29]. The mecha-
nisms by which coronary arteries increase their lumen size in the pres-
ence of atherosclerosis remain unclear. Arterial enlargement may
develop as a result of intimal plaque causing involution of the media
with outward bulging of the lesion [29]. Bond et al. [30] observed sub-
stantial destruction of the tunica media, with dissolution of the internal
elastic lamina and loss of smooth muscle cells. Armstrong et al. [26]
noted diffuse thickening of the intima and focal atrophy and focal thin-
ning of the media, albeit the total medial mass was not decreased. The
degradation of mural connective tissue ﬁbers by enzymes released by
plaque cells has also been suggested as a contributing factor [2]. de
Groot and Veldhuizen [31] have suggested the existence of a diffuse
complex of changes that start with a gradual enlargement of the vessel
followed by narrowing, with associated changes in the intima, media
and adventitia.
Wall shear stress (WSS) can be estimated by Poiseuille's law, which
states that shear stress is proportional to ﬂow viscosity and inversely
proportional to the third power of the internal radius [32]. Arterial
lumen enlargement has been shown to occur in response to long-term
increase in ﬂow velocity and to continue until a normal level of WSS is
restored [32,33]. The narrowing of the lumen caused by intimal hyper-
plasia or plaque deposition tends to increase ﬂow velocity and WSS,
which stimulates endothelial-dependent arterial dilation. Since ﬂow
did not change in our study and the lesions were fairly minor (b5% ste-
nosis and normal FFR), the shear stress effectwas likely not important in
this study.
It has also been demonstrated [34] that a decrease in blood viscosity
at a constant ﬂow rate leads to arterial narrowing, whereas an increase
in blood viscosity causes arterial enlargement. Although we did not
Fig. 5.A) Linear regression analysis between IVUS lumen area and CCTA lumen area; R2=
0.68. B) Bland–Altman accuracy analysis between both imaging modalities; mean of dif-
ference = 0.06 mm2, +2SD = 2.97 mm2,−2SD = 2.85 mm2.
Fig. 6. A) Percent stenosis of LAD, LCX and RCA at 4 months of atherogenic diet (Group I).
B) Percent stenosis of LAD artery at 4 (Group I) and 12 months (Group II) of atherogenic
diet. C) FFR at baseline and at 4 months (Group I). The data is expressed as mean ± 1SD.
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increased in animals fedwith an atherogenic diet [35] and in hypercho-
lesterolemic patients [36]. The increase in blood viscosity previously re-
ported varies from 0.8% to 8.2% [37–39]. In hemodynamic studies of
early atherosclerotic changes [26], vascular resistance was found to be
increased in the resting state and also during maximal vasodilation.
The greater viscosity of hypercholesterolemic blood may contribute to
this ﬁnding, since lumen area is maintained or even increased. If we as-
sume a 10% increase in blood viscosity in these animals, then a 3% in-
crease in diameter would be expected to maintain uniform shear
stress. Clearly, the increase in lumen CSA found in this study (mean of
25%) cannot be explained by the increase in viscosity, and hence, WSS.
In longitudinal animal studies, the enlargement of coronary arteries
can be attributed to animal growth and differences in bodyweight. Ath-
erosclerotic progression and regression experiments [26,30], however,
have demonstrated that animals fed an atherogenic diet hadmuch larg-
er coronary arteries as compared to control groups, suggesting that in
growing animals, atherosclerosis results in increased arterial size. The
mean heart weights in our study were 183 g and 228 g at baseline and
at 4 months, respectively. Given that CSA is proportional to M2/3 [40],
an approximately 15.7% increase in CSA would be expected. Hence,
the greater lumen CSA found in this study cannot be attributed to ani-
mal and heart growth alone. Finally, diabetes mellitus, race, and sexare also minor determinants of artery size, while hypertension and cig-
arette smoking seems to have no independent inﬂuence on vessel size
[29].
The differential degree of lumen remodeling in the three major cor-
onary arteries is interesting. The IVUS studies suggest a greater increase
in lumenCSA in the order of RCA N LAD N LCX. Thiswas supported by the
CT images, which suggest LAD N LCX. This may depend on the degree to
which the vessel is supported by surrounding myocardium. The RCA
tends to be most superﬁcial and transverses along the base without
penetrating into the myocardium, unlike the LAD and LCX. Hence, the
RCAmay be less restricted to expand radially due to the lack of myocar-
dial restraint. The effect of surrounding tissue has clearly been shown to
affect remodeling of vessels during pressure-overload [41].
Finally, positive coronary arterial remodeling has also been associat-
ed with stent malapposition after drug-eluting stent implantation [42].
Several studies have reported that positive remodeling was the main
cause of late-acquired incomplete apposition,whichwas also associated
with late and very late stent thrombosis [43–45].
Fig. 7. Lumen area versus percent stenosis from seven Ossabaw pigs (Group II) after 12
months of atherogenic diet.
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associated with a compensatory enlargement of the vessel cross-
sectional area, which results in paradoxical lumen expansion, at the
earlier stages of atherosclerosis. The conﬁrmation of the Glagov phe-
nomenon in the Ossabaw animal model will lend to studies that may
yield important new insights for the diagnosis, prevention and treat-
ment of ischemic heart disease, especially for patients with metabolic
syndrome, in whom there is a strong association with plaque vulnera-
bility [46].
4.1. Study limitations
This studywas designed to evaluate the remodeling process induced
by the atherogenic diet up to 8 months. Unfortunately, animals devel-
oped cardiac arrest during CCTA imaging at 8 months, precluding us
from obtaining additional longitudinal data beyond 4 months. Ossabaw
pigs on an atherogenic diet are well known to be more susceptible to
myocardial infarction as compared to domestic pigs. Hence, we consid-
ered a separate group of Ossabaw at 12months. Although themeasure-
ments at 12 months were made in a different group of animals, their
weights were similar at the beginning of the study, and both groups
were fed the same atherogenic diet. Furthermore, two independent in-
vestigators analyzed the baseline and 4months and the 12months data,
respectively.
Body weight-matched Yorkshire domestic pigs were used as the
control group because Ossabaw miniature pigs do not grow or gain
body weight when they are fed a lean diet. Compared with the lean do-
mestic Yorkshire pig, the lean Ossabaw grows more slowly and has less
muscle mass. The Yorkshire pigs have greater cellularity and cell size in
the skeletalmuscle. Subcutaneous fat thickness is at least twofold great-
er in obese Ossabaw pigs than in Yorkshire. Ossabaw obese pigs are not
hyperglycemic or hyperinsulinemic relative to the lean Yorkshire but
they do have reduced glucose tolerance and lower plasma growth hor-
mone [47]. Despite the use of different species in this study, the differ-
ences in coronary anatomy are not expected to be signiﬁcant and the
positive remodeling in the distal coronary arteries (3–4 cm distal of
main branch) is apparent (Fig. 2).
IVUS and CCTA imaging are limited by difﬁculties in matching single
CSA at different time points. Although every effort was made to match
the sites at baseline and at 4 months, matching may be imperfect at
some points.Weused the arterial branches as reference points, and nor-
malized the data according to fractional longitudinal position for both
methods. Finally, this atherosclerosis progression study only evaluated
the atherosclerotic changes in coronary arteries for a relatively short pe-
riod of time.
Although some studies using multislice CT angiography have failed
to provide positive results in the primary prevention settings, new ad-
vances in imaging technology and computational sciences may allowthe development of patient-speciﬁc models of coronary artery disease
to accurately predict and prevent future cardiac events.
4.2. Signiﬁcance
This is the ﬁrst atherosclerosis progression study to demonstrate en-
largement of the coronary arteries in a metabolic syndrome animal
model with diffuse disease. Positive remodeling may represent an
early marker of disease and an indication of future adverse events espe-
cially in patients with metabolic syndrome. Subjects with metabolic
syndrome usually have multivessel involvement, more positive remod-
eling, and non-calciﬁed plaques than those without metabolic
syndrome. Positive remodeling in the early stages of coronary athero-
sclerosis often results in plaque rupture and acute events due to the
higher lipid content and macrophage count in these plaques [48], thus
requiring an accurate diagnosis. A better understanding of these ﬁnd-
ings should provide direction for the development of new algorithms
to improve detection and management of coronary artery disease.
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